Literature DB >> 8414736

Spirometry in the asthmatic child: is FEF25-75 a more sensitive test than FEV1/FVC?

P Lebecque1, P Kiakulanda, A L Coates.   

Abstract

The use of spirometry in the assessment of children with asthma is taking on new importance with the realization that considerable airway obstruction may exist in the absence of clinically detectable abnormalities. There has been controversy over the value and relative sensitivity of various spirometry indices. This study evaluated the forced expiratory flow between 25% and 75% of vital capacity (FEF25-75), forced expired volume in 1 second (FEV1), and the ratio between the FEV1 and the forced vital capacity (FVC) in 100 asthmatic children aged 6-17 years, 29 of whom were wheezing at the time of the evaluation. All children with clinical wheezing had a FEV25-75 < 2 standard deviations (SD) below the mean (-2 SD), whereas 8 had a normal FEV1. The majority of the wheezing children had abnormalities of all 3 indices, whether expressed as < or = -2 SD or, in the case of the FEV1/FVC, arbitrarily taken as < 80%. Sixty-seven children of the entire study group had at least 1 abnormal spirometric index, but 38 of these had no clinical abnormalities. Twelve children had a reduced FEF25-75 as the only abnormality. These results suggest that FEF25-75 is a sensitive index of airway obstruction.

Entities:  

Mesh:

Year:  1993        PMID: 8414736     DOI: 10.1002/ppul.1950160105

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  26 in total

1.  Acid suppression does not change respiratory symptoms in children with asthma and gastro-oesophageal reflux disease.

Authors:  K Størdal; G B Johannesdottir; B S Bentsen; P K Knudsen; K C L Carlsen; O Closs; M Handeland; H K Holm; L Sandvik
Journal:  Arch Dis Child       Date:  2005-09       Impact factor: 3.791

2.  Mid-expiratory flow versus FEV1 measurements in the diagnosis of exercise induced asthma in elite athletes.

Authors:  J W Dickinson; G P Whyte; A K McConnell; A M Nevill; M G Harries
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

3.  Relationship among pulmonary function, bronchial hyperresponsiveness, and atopy in children with clinically stable asthma.

Authors:  Eugene Yang; Woojung Kim; Byoung Chul Kwon; Sung Yeon Choi; Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

4.  Cytokine gene polymorphism and asthma susceptibility, progress and control level.

Authors:  Saeed Daneshmandi; Ali Akbar Pourfathollah; Zahra Pourpak; Hasan Heidarnazhad; Parisa Amir Kalvanagh
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

5.  Population intervention models to estimate ambient NO2 health effects in children with asthma.

Authors:  Jonathan M Snowden; Kathleen M Mortimer; Mi-Suk Kang Dufour; Ira B Tager
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-09-03       Impact factor: 5.563

6.  Obesity and its correlation with spirometric variables in patients with asthma.

Authors:  Alaa E Ghabashi; Mobeen Iqbal
Journal:  MedGenMed       Date:  2006-03-01

7.  Patterns of changes and diagnostic values of FEF50%, FEF25%-75% and FEF50%/FEF25%-75% ratio in patients with varying control of bronchial asthma.

Authors:  Mohamed Faisal Lutfi
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

8.  Shared and distinct genetic influences among different measures of pulmonary function.

Authors:  Terrie Vasilopoulos; Michael D Grant; Carol E Franz; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; William S Kremen; Kristen C Jacobson
Journal:  Behav Genet       Date:  2013-01-09       Impact factor: 2.805

9.  Spirometry in primary care.

Authors:  Allan L Coates; Brian L Graham; Robin G McFadden; Colm McParland; Dilshad Moosa; Steeve Provencher; Jeremy Road
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

10.  The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity.

Authors:  Devika R Rao; Jonathan M Gaffin; Sachin N Baxi; William J Sheehan; Elaine B Hoffman; Wanda Phipatanakul
Journal:  J Asthma       Date:  2012-06-28       Impact factor: 2.515

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.